Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170027/S018

TherOx Downstream System

Zoll Circulation, Inc. · Decision date Apr 10, 2026

FDA DECISIONP170027/S018

What did the FDA approve?

FDA records P170027/S018 as a supplement to PMA P170027, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Apr 10, 2026.

FDA approval order statement

approval of the revised protocol for the post-approval study (PAS)
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Apr 10, 2026
FDA change category
Postapproval Study Protocol

FDA source record

Regulatory record facts

Identifier
P170027/S018
Regulatory pathway
PMA supplement
Product code
MWG
Decision code
APPR
Decision date
Apr 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, oxygen, aqueous.

Product code
MWG
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P170027/S018 received

    Application receipt date recorded by FDA.

  2. P170027/S020 · Related supplement

    TherOx Downstream System

  3. P170027/S018 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P170027. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170027

Product / regulatory recordCompanyPathwayDecision dateSource
Zoll Circulation, Inc.PMA supplementOct 29, 2025FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zoll Circulation, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2000 Ringwood Ave., San Jose, CA, 95131

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records